Terumo (OTCMKTS:TRUMY) Sees Large Volume Increase - Here's What Happened

Key Points

• Terumo Corp. experienced a 54% increase in trading volume with 243,202 shares traded on Tuesday, highlighting heightened investor interest.
• The company reported $0.20 earnings per share (EPS) for the last quarter, surpassing expectations of $0.17, despite revenues of $1.76 billion which fell short of the $1.80 billion estimate.
• Currently, Terumo has a market capitalization of $26.47 billion and shows a solid financial position with a current ratio of 2.64 and a low debt-to-equity ratio of 0.07.

Shares of Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 243,202 shares changed hands during trading, an increase of 54% from the previous session's volume of 158,095 shares.The stock last traded at $17.92 and had previously closed at $17.97.

Terumo Stock Up 0.6%

The company has a quick ratio of 1.53, a current ratio of 2.64 and a debt-to-equity ratio of 0.07. The company's fifty day simple moving average is $17.57 and its 200 day simple moving average is $18.20. The firm has a market capitalization of $26.43 billion, a PE ratio of 31.32 and a beta of 0.79.

Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. Terumo had a return on equity of 9.19% and a net margin of 12.09%.The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.80 billion.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.